Compare, Analyse Dr. Reddys with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
ADCOCK INGRAM
Jun-14
DR. REDDYS LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,363352-   
Low Rs2,352254-   
Sales per share (Unadj.) Rs1,054.2104.8-  
Earnings per share (Unadj.) Rs121.9-26.4-  
Cash flow per share (Unadj.) Rs190.2-21.9-  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs938.782.3-  
Shares outstanding (eoy) m166.17168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.72.9 93.7%   
Avg P/E ratio x23.4-11.5 -204.1%  
P/CF ratio (eoy) x15.0-13.9 -108.4%  
Price / Book Value ratio x3.03.7 82.6%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m474,83151,185 927.7%   
No. of employees `00021.74.3 504.3%   
Total wages/salary Rs m33,8023,212 1,052.2%   
Avg. sales/employee Rs Th8,091.04,120.8 196.3%   
Avg. wages/employee Rs Th1,561.3748.3 208.6%   
Avg. net profit/employee Rs Th935.8-1,038.3 -90.1%   
INCOME DATA
Net Sales Rs m175,17017,690 990.2%  
Other income Rs m6,206124 5,009.6%   
Total revenues Rs m181,37617,814 1,018.1%   
Gross profit Rs m24,421-3,066 -796.6%  
Depreciation Rs m11,348764 1,486.3%   
Interest Rs m983479 205.1%   
Profit before tax Rs m18,296-4,184 -437.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,403261 -536.6%   
Profit after tax Rs m20,260-4,458 -454.5%  
Gross profit margin %13.9-17.3 -80.4%  
Effective tax rate %-7.7-6.2 122.7%   
Net profit margin %11.6-25.2 -45.9%  
BALANCE SHEET DATA
Current assets Rs m125,99112,957 972.4%   
Current liabilities Rs m72,1417,290 989.6%   
Net working cap to sales %30.732.0 96.0%  
Current ratio x1.71.8 98.3%  
Inventory Days Days73111 65.9%  
Debtors Days Days105124 84.5%  
Net fixed assets Rs m83,8547,552 1,110.3%   
Share capital Rs m83182 1,011.8%   
"Free" reserves Rs m155,1570-   
Net worth Rs m155,98813,885 1,123.4%   
Long term debt Rs m1,3044,879 26.7%   
Total assets Rs m232,25326,230 885.5%  
Interest coverage x19.6-7.7 -253.6%   
Debt to equity ratio x00.4 2.4%  
Sales to assets ratio x0.80.7 111.8%   
Return on assets %9.1-15.2 -60.3%  
Return on equity %13.0-32.1 -40.5%  
Return on capital %12.6-19.8 -63.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m44,5770-   
CASH FLOW
From Operations Rs m29,8411,510 1,976.2%  
From Investments Rs m-4,923-464 1,061.8%  
From Financial Activity Rs m-25,1594,428 -568.1%  
Net Cashflow Rs m-2665,475 -4.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.86 Rs / ZAR

Compare DR. REDDYS LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: NOVARTIS  IPCA LABS  DIVIS LABORATORIES  LUPIN  SHASUN PHARMA  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views On News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Feb 26, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - JUBILANT LIFE SCIENCES COMPARISON

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS